Global Navigation

Sub Men


Not currently logged in
Email:
Password:

1179 General features articles

You are on page 1 of 59. You can search pharmaceutical articles in detail, run a basic keyword search of pharmaceutical articles or search all of PMLiVE.

Digital campaigns: the right time?

Anyone venturing into digital pan-European campaigns is still something of a pioneer, and it can be hugely rewarding for brand owners and agencies alike
07/02/2012
FEATURE
Digital campaigns: the right time?

Understanding the interconnected HTA universe

Pharma needs to identify and understand how individual HTA agencies are connected, viewing them as a network
06/02/2012
FEATURE
Tangled string - understanding the interconnected HTA universe

Major pharma deals during 2011

Deal watch: A look at the biggest mergers and acquisitions from 2011, including Sanofi's purchase of Genzyme and J&J taking over Synthes
03/02/2012
FEATURE
Deal watch - pharma mergers and acquisitions 2011

Pillars of success in market access

The key to true market access success begins with corporate ownership…
02/02/2012
FEATURE
Pillars of success - market acces

Proving value in uncertain times

Industry needs to be perceived as a contributor to healthcare solutions not just a cost
01/02/2012
FEATURE
Question mark euro - Proving value in uncertain times

How to win through integrating market access

Embedding and integrating market access strategies company-wide is key
31/01/2012
FEATURE
Finishing line - How to win in market access

The role of systematic review in market access

Modern market access activities need to be evidence-based. But what does this really mean for new products being taken to market around the world? 
30/01/2012
FEATURE
approved symbol - essential role of systematic review

Country Report: The healthcare market in Spain

Currently facing a major financial crisis, Spain's healthcare system is overstretched with autonomous regions owing millions of Euros to suppliers such as the pharma industry
27/01/2012
FEATURE
Country Report: The healthcare market in Spain

Impact of cardiovascular events on diabetes treatment pipeline

Therapies are facing greater scrutiny to ensure they do not carry increased risk of cardiovascular side effects
27/01/2012
FEATURE
Heart in sugar - impact of cardiovascular events on diabetes treatment pipeline

Were healthcare ads really that good in the 1980s?

How centrally developed advertising campaigns can work in local markets and taking tips from motor industry campaigns can help increase brand engagement
25/01/2012
FEATURE
Cassette tape heart - Were healthcare ads really that good in the 1980s?

Current and future challenges for market access in the UK

A survey of pharma companies shows they are hiring expert help to cope with the problems of an increasingly fragmented market in the UK
24/01/2012
FEATURE
Hurdles - current and future challenges for market access in the UK

Become ‘patient intelligent’ to cure treatment aversion

Patients seldom refuse therapy outright, but often show a reluctance to comply. Understanding the reasons for this is the first step to improving their treatment
23/01/2012
FEATURE
Spilt pills - become patient intellegent to cure treatment aversion

Influence of iPad and mobile in pharma

When Apple's Steve Jobs unveiled the iPad in early 2010, he probably did not anticipate that the tablet would challenge the business laptop market so quickly
20/01/2012
FEATURE
Upwardly mobile pharma

The link between smoking and ill health

This month in pharma: January 1964, and the publication of the US Surgeon General's 'Smoking and Health' report
19/01/2012
FEATURE
Smoking and Health US Surgeon General report, 1964

EudraVigilance Medicinal Product Dictionary requirements

The new regulation has caught many in the industry off guard and the European Medicines Agency has given companies just months to respond to this mandate, one of the most expansive regulatory reforms in decades
17/01/2012
FEATURE
Data files - EudraVigilance Medicinal Product Dictionary (EVMPD)

Interview: John Dineen, GE Healthcare

GE Healthcare's president and CEO tells Dominic Tyer about the rising importance of molecular diagnostics and how his company is moving increasingly closer to the biopharmaceutical world
16/01/2012
FEATURE

Gain a deeper understanding of the product launch process

Use best practices to create a cohesive strategy for a successful product launch, whether it is for a small molecule, biologic, vaccine or device
13/01/2012
FEATURE

Pinpoint precision in a brand plan review

It is important to improve the risk-adjusted return on investment ratio when performing the annual brand plan review
12/01/2012
FEATURE
Pinpoint precision in a brand plan review

Market access in the Czech Republic

Though an attractive market potentially, this country has a slow registration procedure and an emphasis on drug cost rather than value
11/01/2012
FEATURE
Czech Republic market access pharma

The positives of PR for pharma

Pharmaceutical public relations fulfils a much more important role than just creating promotional adverts; it is a vital adjunct in educating patients about drugs and diseases
10/01/2012
FEATURE
USA

Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next

Jobs & Careers